1. Home
  2. OPK vs KFRC Comparison

OPK vs KFRC Comparison

Compare OPK & KFRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • KFRC
  • Stock Information
  • Founded
  • OPK 2007
  • KFRC 1962
  • Country
  • OPK United States
  • KFRC United States
  • Employees
  • OPK N/A
  • KFRC N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • KFRC Professional Services
  • Sector
  • OPK Health Care
  • KFRC Consumer Discretionary
  • Exchange
  • OPK Nasdaq
  • KFRC Nasdaq
  • Market Cap
  • OPK 1.0B
  • KFRC N/A
  • IPO Year
  • OPK 1995
  • KFRC 1995
  • Fundamental
  • Price
  • OPK $1.58
  • KFRC $54.84
  • Analyst Decision
  • OPK Strong Buy
  • KFRC Buy
  • Analyst Count
  • OPK 3
  • KFRC 3
  • Target Price
  • OPK $2.75
  • KFRC $66.67
  • AVG Volume (30 Days)
  • OPK 2.9M
  • KFRC 95.7K
  • Earning Date
  • OPK 02-25-2025
  • KFRC 02-03-2025
  • Dividend Yield
  • OPK N/A
  • KFRC 2.78%
  • EPS Growth
  • OPK N/A
  • KFRC N/A
  • EPS
  • OPK N/A
  • KFRC 2.68
  • Revenue
  • OPK $711,408,000.00
  • KFRC $1,405,308,000.00
  • Revenue This Year
  • OPK N/A
  • KFRC N/A
  • Revenue Next Year
  • OPK $0.00
  • KFRC $0.84
  • P/E Ratio
  • OPK N/A
  • KFRC $20.41
  • Revenue Growth
  • OPK N/A
  • KFRC N/A
  • 52 Week Low
  • OPK $0.86
  • KFRC $52.96
  • 52 Week High
  • OPK $1.76
  • KFRC $74.79
  • Technical
  • Relative Strength Index (RSI)
  • OPK 55.91
  • KFRC 35.17
  • Support Level
  • OPK $1.47
  • KFRC $55.15
  • Resistance Level
  • OPK $1.51
  • KFRC $56.64
  • Average True Range (ATR)
  • OPK 0.04
  • KFRC 1.19
  • MACD
  • OPK 0.01
  • KFRC -0.04
  • Stochastic Oscillator
  • OPK 94.44
  • KFRC 3.16

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

Share on Social Networks: